POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

FDA approves Micra, first wire-free pacemaker

Staff writer |
The first leadless, wire-free heart pacemaker has been approved by the U.S. Food and Drug Administration.

Article continues below




Medtronic's Micra Transcatheter Pacing System works like other pacemakers to regulate heart rate in people with heart rhythm disorders, but does not use wired leads to make the electrical connection between the device and the heart.

"The leadless pacemaker is a major breakthrough in the field of heart rhythm management and will benefit patients through its ease of insertion and elimination of the lead," said Dr. Nicholas Skipitaris, who directs cardiac electrophysiology at Lenox Hill Hospital in New York City.

Traditional pacemakers have a wire or "lead" connecting the device to the heart, and inserting the lead entails minor surgery, Skipitaris said.

"Through a small incision near the shoulder, the lead is guided through a blood vessel and attached to the inside surface of the heart," he said. "The other end is connected to the pacemaker, which is then placed in a pocket under the skin. The incision is closed with sutures."

Unfortunately for patients, "leads may sometimes malfunction or become less reliable over the long term," he added.

Leads in traditional pacemakers can sometimes malfunction or infections can develop in tissue surrounding the leads, the FDA said, and surgery is then required to replace the device.

But as the FDA explained, the new inch-long Micra device is implanted directly into the right ventricle chamber of the heart, with no wire lead needed.

"Insertion of the Micra is also easier as it does not require any incision," Skipitaris said. "It is delivered to the heart through a long tube placed in a large vein in the groin area. The self-contained device is then anchored to the heart and the guiding tube is removed," he explained.

Dr. William Maisel is acting director of the Office of Device Evaluation at the FDA's Center for Devices and Radiological Health. He said in an agency news release: "As the first leadless pacemaker, Micra offers a new option for patients considering a single chamber pacemaker device, which may help prevent problems associated with the wired leads."

The Micra pacemaker is meant for patients with a common heart rhythm disorder called atrial fibrillation or those with other dangerous rhythm problems, such as bradycardia-tachycardia syndrome.

The FDA approval is based on a clinical trial of 719 patients who received the Micra device. Six months after implantation, 98 percent of the patients had adequate heart pacing.

Complications occurred in less than 7 percent of the study participants and included extended hospital stays, blood clots in the legs and lungs, heart injury, heart attack and dislocation of the pacemaker, the FDA said.


What to read next

FDA seeks permanent injunctions against two stem cell clinics
Magnetized wire could be used to detect cancer
Dramatic increase in e-cigarette use among youth in U.S.